Accession Number: | 0001209191-21-025366 |
Date: | 2021-03-01 |
Issuer: | INOGEN INC (INGN) |
Original Submission Date: | 2021-03-03 |
SHABSHAB NABIL
C/O INOGEN, INC.
326 BOLLAY DRIVE
GOLETA, CA 93117
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
RESTRICTED STOCK UNIT | 0.0 | 2021-03-01 | deemed execution date | A | 33,872 (a) | common stock 33,872 | $0.00 | 33,872 | direct |
ID | footnote |
---|---|
f1 | each restricted stock unit represents a contingent right to receive one share of inogen common stock. |
f2 | originally filed form 4 reported 16,936. |
f3 | subject to the reporting person's continued service, 50% of the restricted stock units will vest on march 1, 2023, and the remaining 50% of therestricted stock units will vest in 1/8th quarterly installments over the following 2 years. |
f4 | originally filed form 4 reported incorrect vesting schedule. |